scholarly journals Invasive Solid Mucinous Papillary Carcinoma Breast with Neuroendocrine Differentiation: A Case Report with Immunohistochemical Study

2020 ◽  
Vol 7 (9) ◽  
pp. C111-114
Author(s):  
Jyoti Mishra ◽  
Srijan Srivastav ◽  
Natasha Singh ◽  
Varun Prasad
Keyword(s):  
Older Women ◽  
Papillary Carcinoma ◽  
Immunohistochemical Study ◽  
Neuroendocrine Differentiation ◽  
Correct Identification ◽  
Carcinoma Of The Breast ◽  
Carcinoma Breast ◽  
Favorable Prognosis ◽  
Solid Papillary Carcinoma ◽  
Cytological Features

Solid papillary carcinoma of the breast (SPCB) is a distinctive form of papillary carcinoma that tends to occur in older women and usually has a favorable prognosis. We describe an invasive solid papillary carcinoma with extracellular and intracellular mucin and neuroendocrine differentiation in a 60-year old female. The cytological features have been also been highlighted with an insight on differentials that were helpful in its correct identification preoperatively.

scholarly journals Invasive solid papillary carcinoma with neuroendocrine differentiation of the breast: a case report and literature review

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Xue Lin ◽  
Yoshiaki Matsumoto ◽  
Tomomi Nakakimura ◽  
Kazuo Ono ◽  
Shigeaki Umeoka ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Papillary Carcinoma ◽  
Neuroendocrine Differentiation ◽  
Solid Papillary Carcinoma

scholarly journals Solid papillary carcinoma of the breast

2022 ◽  
Vol 12 ◽  
pp. e2021352
Author(s):  
Toyaja Jadhav ◽  
Shashi Shekhar Prasad ◽  
Bhupesh Guleria ◽  
Manvir Singh Tevatia ◽  
Prerna Guleria
Keyword(s):  
Papillary Carcinoma ◽  
Carcinoma Of The Breast ◽  
Solid Papillary Carcinoma

Solid papillary carcinoma of the breast: A special entity needs to be distinguished from conventional invasive carcinoma avoiding over-treatment

The Breast ◽  
2016 ◽  
Vol 26 ◽  
pp. 67-72 ◽  
Author(s):  
Shuangping Guo ◽  
Yingmei Wang ◽  
Joseph Rohr ◽  
Chaoliang Fan ◽  
Qinglong Li ◽  
...  
Keyword(s):  
Papillary Carcinoma ◽  
Invasive Carcinoma ◽  
Carcinoma Of The Breast ◽  
Solid Papillary Carcinoma

INSM1 immunostaining in solid papillary carcinoma of the breast

2020 ◽  
Author(s):  
Noritaka Kudo ◽  
Jun Takano ◽  
Shinji Kudoh ◽  
Nobuyuki Arima ◽  
Takaaki Ito
Keyword(s):  
Papillary Carcinoma ◽  
Carcinoma Of The Breast ◽  
Solid Papillary Carcinoma

Solid Papillary Carcinoma of the Breast: Report of Two Cases

2001 ◽  
Vol 25 (2) ◽  
pp. 147-152 ◽  
Author(s):  
Chizuko Kanbayashi ◽  
Kuniyuki Oka ◽  
Hando Hakozaki ◽  
Hidetoshi Saito ◽  
Norimasa Sando ◽  
...  
Keyword(s):  
Papillary Carcinoma ◽  
Carcinoma Of The Breast ◽  
Solid Papillary Carcinoma

scholarly journals Neuroendocrine Differentiation in Breast Cancer: Clinicopathological Significance of Bcl-2 Positive Solid Papillary Carcinoma

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Yoichiro Okubo ◽  
Takuji Okubo ◽  
Yoshimi Okubo ◽  
Takao Ishiwatari
Keyword(s):  
Breast Cancer ◽  
Papillary Carcinoma ◽  
Neuroendocrine Tumors ◽  
Ductal Carcinoma ◽  
Neuroendocrine Differentiation ◽  
Prognostic Indicator ◽  
Low Grade ◽  
Term Survival ◽  
Solid Papillary Carcinoma ◽  
Poor Prognostic Indicator

Solid papillary carcinoma (SPC) is considered a rare malignant breast tumor. Maluf and Koerner first reported this disease entity as a special type of ductal carcinoma in situ with several characteristic histopathological features, including low-grade cellular atypia, intracellular or extracellular mucin deposition, and solid papillary growth pattern, as well as neuroendocrine differentiation. The present paper describes a case of SPC with bcl-2 expression, which is known as a marker for malignancy of neuroendocrine tumors. Interestingly, despite bcl-2 expression being a poor prognostic indicator of neuroendocrine tumors, the patient with this tumor has achieved long-term survival (approximately 6 years) at the time of writing this report. Because previous investigators reported that bcl-2 expression might play a role in the inhibition of the development of breast cancer, we suggest that bcl-2 expression might reflect a good prognosis in patients with SPC, rather than being a poor prognostic indicator, as it is in several types of neuroendocrine tumor. However, to confirm this hypothesis, further investigation is required.

Sign in / Sign up

Export Citation Format

Share Document